Becton Dickinson Q2 Revenues Up 5 Percent | GenomeWeb

This article has been updated to include comments from BD's earnings call.

NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal second quarter revenues rose 5 percent year over year.

For the three months ended March 31, the Franklin Lakes, New Jersey-based company posted revenues of $3.07 billion compared to $2.05 billion in the year-ago quarter, in line with analysts' average estimate.

On an adjusted, currency-neutral basis Q2 revenues rose 55 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.